Revalesio

Tacoma, WA · Founded 2000 · Privately Held (backing)

Developer of an anti-inflammatory therapeutic drug designed to treat a variety of neurological diseases. Revalesio is based in Tacoma, WA and was founded in 2000. Its last reported valuation was $86.4 million in Jul 2020. It has raised $113 million across 6 recorded rounds; the latest was a $38.9 million early-stage round in May 2022.

Last reported valuation
$86.4M
Oct 2026
Priced at
—
Total raised
$112.8M
Last round
Early Stage VC
May 2022

Who backs Revalesio?

2 investors
InvestorType
Cumming Capital ManagementFamily office
ALS—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Revalesio investors

2 investors are on record for Revalesio, including Cumming Capital Management and ALS. The early-stage round in May 2022 drew 31 investors.

Free account
More of Revalesio with a free account
  • ·Watch Revalesio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 2 firms already write checks for companies like Revalesio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View